Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$13.70 USD
+0.08 (0.59%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $13.69 -0.01 (-0.07%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: AMC |
6/2024 | $-0.21 | 0.81% |
Earnings Summary
For their last quarter, Perspective Therapeutics, Inc. (CATX) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 33.33%. Look out for CATX's next earnings release on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 47.5%.
Earnings History
Price & Consensus
Zacks News for CATX
PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
CATX: What are Zacks experts saying now?
Zacks Private Portfolio Services